Background. Fluoroquinolones (FQ) have the potential for serious side effects such as tendonitis and tendon rupture, QTc prolongation, severe neuropathies, Clostridium difficile infection, dysglycemia, and AKI in patients on ACE inhibitors or ARBs. Beginning in 2016, the University of Chicago Medicine (UCM) Antibiotics Stewardship Program began to give targeted feedback and education to outpatient clinic areas regarding their FQ use to reduce the number of prescriptions.
Methods. Outpatient FQ prescribing data from July 2015 to June 2016 (pre-intervention) and December 2016 to December 2017 (post-intervention) was reviewed retrospectively to evaluate indications, durations and alternatives for FQ prescriptions. Education and targeted feedback specific to the clinical area on current FQ usage was given by peer-comparison or aggregate data with recommendations for improved prescribing practices. The number of ciprofloxacin prescriptions/1,000 clinic visits was evaluated in two outpatient clinics and number of ciprofloxacin prescriptions/1,000 patient discharges was evaluated in the emergency department pre and post intervention. FQ use in the two time periods was compared using the unpaired T-test.
Results. Ciprofloxacin use in the primary care group (PCG) (12.9%), student care (SC) (7.1%), and emergency department (ED) (8.6%) accounted for 28.6% of overall Ciprofloxacin use in the pre-intervention time period. A significant decrease in ciprofloxacin prescribing was seen in the PCG, 8.78Rx/1,000 patient visits (PRE) vs. 5.24Rx/1,000 patient visits (POST), P < 0.001; in SC, 16.25 Rx/1,000 patient visits (PRE) vs. 6.76Rx/1,000 patient visits (POST), P < 0.001; and the ED, 13.37RX/1,000 patient discharges (PRE) vs. 9.84/1,000 patient discharges (POST) (P = 0.035). Peer comparison data were well received by PCG faculty. Decreases have been sustained in each clinical area 4 (ED) to 12 months (PCG and student care) following the intervention.
Conclusion. Feedback on both aggregate clinic and individual use of ciprofloxacin resulted in decrease use in three outpatient clinical areas at UCM and was well received by providers. Further work is up needed to assess the most effective methods to optimize antibiotic prescribing in the ambulatory clinics.
Disclosures. Background. Fluoroquinolone (FQ) use is associated with the development of C. difficile colitis, emergence of multidrug-resistant pathogens and occurrence of multiple adverse effects. In light of these risks, the Food and Drug Administration (FDA) warns against the overuse of systemic FQs for certain infections. Utilization of clinical decision support systems or alert tools integrated within the computerized physician order entry (CPOE) have been implemented in the inpatient setting to reduce antibiotic use. However, there is limited data on the effectiveness of such strategies in the outpatient setting. The purpose of this study was to evaluate the impact of an antimicrobial stewardship initiative on FQ utilization in the outpatient setting.
Methods. This was a retrospective chart review of patients ≥18 years old who received a FQ upon discharge from the inpatient setting, emergency department or outpatient clinics at a large academic medical center. The intervention consisted of an automatic electronic alert that would appear upon prescribing of a FQ, suggesting use of an alternative antibiotic and requiring a diagnosis to be entered. The pre and post intervention periods spanned from November 16, 2016 to April 16, 2017 and from November 16, 2017 to April 16, 2018, respectively. The primary endpoint was the number of FQ prescriptions over the total number of visits in the pre-and post-intervention time periods. A secondary endpoint was days of therapy (DOT) on an FQ.
Results. 1,668 patients received FQs upon discharge in the pre-intervention arm and 1,494 in the post-intervention arm. Compared with the pre-intervention group, fewer FQs were prescribed in the post intervention group (P = 0.002). Fewer patients were discharged on an FQ from the outpatient clinics in the post-intervention arm compared with the pre-intervention arm (31 vs. 39%). However, this did not hold true when evaluating the number of FQ prescriptions written from the inpatient setting (52% in the post and 42% in the pre-intervention). DOT was lower in the post-intervention arm (10,751.5) compared with the pre-intervention period (11, 961) .
Conclusion. Implementation of a mandatory electronic alert tool in CPOE showed a statistically significant reduction in the overall number of FQ prescriptions between the pre and post intervention groups in the outpatient setting.
Disclosures. All authors: No reported disclosures. 
Rethinking Empirical Treatment for Urinary Tract Infections in the
Methods. For 2 months, PC clinicians were instructed to alter practice by sending a UA with reflex to culture for all patients suspected of having UTI. A retrospective chart review collected antibiotic prescriptions, UA and culture results. We generated a combination UTI-specific antibiogram (CUSA) based on data from all urine cultures sent from this clinic. Using the CUSA we developed an empirical UTI treatment algorithm and evaluated prescribing trends before and after its implementation.
Results. The CUSA as compared with the E. coli urinary antibiogram for the PC clinic is shown in Table 1 . Distribution of organisms is represented by Figure 1 . Based on the CUSA, a treatment algorithm was developed that included preference for nitrofurantoin and TMP/SMX for patients with cystitis, and allowed for use of TMP/ SMX even in pyelonephritis cases without risk factors for resistance. Cephalosporins were advised over fluoroquinolones. Of 304 patients in whom urine cultures were sent pre-implementation, 178 empirical antibiotic prescriptions were written, while 126 were written for 388 patients after implementation. Nitrofurantoin prescriptions increased (47% to 55%), TMP/SMX (19%) and cephalosporin use (4%) remained the same, and fluoroquinolone prescribing decreased (28% to 20%).
Conclusion. We used a CUSA to develop a treatment guideline more reflective of our causative pathogens and institutional resistance patterns. We saw a shift in usage from antibiotics with more to antibiotics with less collateral damage. Background. Antimicrobial therapy for asymptomatic bacteriuria (ASB) is often unnecessary and is a common reason for inappropriate antimicrobial use in hospitalized patients. ASB treatment leads to development of resistance, drug toxicities and increased risk of Clostridium difficile infections. We evaluated a multi-faceted interdisciplinary antimicrobial stewardship approach to reduce unnecessary antimicrobial utilization for ASB.
Methods. This was an IRB approved study evaluating the impact of antimicrobial stewardship on antibiotic utilization for ASB in a pilot medical-surgical unit. The pre-intervention phase was from August to October 2017 and the post-intervention phase was from December to March 2018. The intervention phase consisted of educational in-services to hospitalist groups, Infectious Diseases physicians, nurses, and pharmacists. An electronic real-time surveillance system was used to identify positive urine cultures. The clinical pharmacist for the pilot unit classified the patient as either ASB or urinary tract infection, and made stewardship interventions to stop unnecessary antimicrobial therapy for ASB.
Results. There were 65 and 77 patients with bacteriuria in the pre-and post-intervention phases. Among these, ASB was present in 29 (45%) and 27 (35%) patients, respectively. After excluding those receiving antibiotics for concurrent non-urinary indications, education alone decreased ASB treatment from 18 (62%) to 12 (44%) patients in the pre-and post-intervention phases respectively [RR 0.72, P = 0.19] . Pharmacist interventions in combination with education further decreased unnecessary ASB treatment from 18 (62%) to 6 (22%) patients [RR 0.36, 95% CI 0.16-0.72, P = 0.003].
Conclusion. Education to healthcare professionals alone did not significantly decrease unnecessary ASB treatment. However, in combination with real-time pharmacist interventions there was a significant decrease in antimicrobial therapy for ASB. With increasing antimicrobial resistance, healthcare institutions should evaluate the role of interdisciplinary antimicrobial stewardship interventions to reduce unnecessary antimicrobial utilization for ASB.
Disclosures. Methods. An assessment instrument was developed through literature review, expert opinion and validated with a logistic model. Patients receiving OPAT in 2017 were randomly selected and retrospectively reviewed based on annual patient volume from 14 OPAT practices. The table shows the ASP assessment tool consisting of 7 Core Elements (CE) scored at 10 points each and 6 Other Elements (OE) scored at 5 points each. Logistic regression was used to validate the relationship between the composite outcome elements and all other elements (aOR = 0.929, P = 0.0005, c = 0.704). Appropriateness of empiric tx and tx length was evaluated using evidence-based guidelines. Each patient OPAT course was assessed and scored for compliance to required elements with an achievable score per patient of 100 points (100%). IV to PO conversion was evaluated secondarily. Descriptive statistics were used.
Results. A total of 200 OPAT courses were scored for compliance to each ASP element as noted in the table. The overall compliance rate for CE and OE was 93.0% and 93.3%, respectively. All CEs were ≥90% compliant, except for duration of tx. This exceeded guidelines in 15% of patient courses due to severe disease presentation. For the OEs, all achieved ≥90% compliance except laboratories performed as ordered. Early conversion from IV to PO resulted in a reduction of 240 IV days for 1.2 days per patient.
Conclusion. We successfully developed an OPAT ASP with national expansion. Opportunities were identified for improvement in laboratory processes and enhanced evaluation regarding tx durations. This validated ASP provides a valuable tool for OPAT, incorporating key elements for stewardship success.
